DRIFT-1: Redcliffe Labs and Skyroot Aerospace will test dry diagnostic reagents in Low Earth Orbit for 90 days to explore diagnostics in space.
Read MoreDiagnostic technology
OptraSCAN Secures FDA 510(k) Clearance for HER2 Digital Pathology Platform
OptraSCAN receives USFDA 510(k) clearance for its integrated digital pathology system supporting HER2 assessment and clinical pathology workflows.
Read More